ACM
BHVN icon

ADAR1 Capital Management’s Biohaven BHVN Stock Holding History

ADAR1 Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$379K Buy
44,777
+10,500
+31% +$115K 0.02% 220
2025
Q4 		$387K Buy
34,277
+9,936
+41% +$123K 0.03% 199
2025
Q3 		$365K Sell
24,341
-8,000
-25% -$116K 0.03% 155
2025
Q2 		$456K Buy
32,341
+9,700
+43% +$173K 0.07% 122
2025
Q1 		$544K Buy
+22,641
New +$798K 0.1% 100
2024
Q4 		– Sell
-2,637
Closed -$132K – 229
2024
Q3 		$132K Buy
+2,637
New +$103K 0.02% 179
2024
Q2 		– Sell
-200
Closed -$10.9K – 278
2024
Q1 		$10.9K Buy
+200
New +$9.9K ﹤0.01% 226

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return